Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia

Blood

Volumn 115, Issue 8, 2010, Pages 1519-1529

  Vinh, Donald C ^a   Patel, Smita Y ^a   Uzel, Gulbu ^a   Anderson, Victoria L ^a   Freeman, Alexandra F ^a,b   Olivier, Kenneth N ^a   Spalding, Christine ^a   Hughes, Stephen ^c   Pittaluga, Stefania ^d   Raffeld, Mark ^d   Sorbara, Lynn R ^d   Elloumi, Houda Z ^a   Kuhns, Douglas B ^b   Turner, Maria L ^d   Cowen, Edward W ^d   Fink, Danielle ^b   Long Priel, Debra ^b   Hsu, Amy P ^a   Ding, Li ^a   Paulson, Michelle L ^a   Whitney, Adeline R ^e   Sampaio, Elizabeth P ^a   Frucht, David M ^f   DeLeo, Frank R ^e   Holland, Steven M ^a   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIMYCOBACTERIAL AGENT; ANTINEOPLASTIC AGENT; AUTOANTIBODY; BACTERIUM ANTIBODY; CASPOFUNGIN; CORTICOSTEROID; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; IMMUNOGLOBULIN; ITRACONAZOLE; POSACONAZOLE; PREDNISONE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ADULTHOOD; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; B LYMPHOCYTE; BACTERIAL PNEUMONIA; BOWEN DISEASE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CHILD; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOPENIA; EPSTEIN BARR VIRUS; ERYTHEMA NODOSUM; FAMILY; FEMALE; FUNGUS; GENITAL TRACT INFECTION; HISTOPLASMOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LEG DISEASE; LEG ERYTHEMATOUS NODULE; LEIOMYOSARCOMA; LOWER RESPIRATORY TRACT INFECTION; LUNG ALVEOLUS PROTEINOSIS; LUNG INFILTRATE; LUNG NODULE; LUNG SARCOIDOSIS; LYMPHOCYTOPENIA; MACROPHAGE; MALE; MELANOMA; MONOCYTOPENIA; MOULD; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOSIS; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PANNICULITIS; PAPILLOMA VIRUS; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; SEPSIS; T LYMPHOCYTE; UPPER RESPIRATORY TRACT INFECTION; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; VULVA; VULVA CARCINOMA; BLOOD; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETICS; LEUKOCYTE COUNT; LEUKOPENIA; MIDDLE AGED; NEOPLASM; PAPILLOMAVIRUS INFECTION; PEDIGREE;

ADOLESCENT; ADULT; CHILD; FEMALE; FUNGI; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTE COUNT; LEUKOPENIA; MALE; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; MYCOSES; MYELODYSPLASTIC SYNDROMES; NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PEDIGREE;

EID: 77949902065     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-03-208629     Document Type: Article

References (60)

1. Al-Muhsen S, Casanova J-L. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008;122(6):1043-1051; quiz 1052.
2. Holland SM. Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity. Immunol Res. 2007;38(1):342-346.
3. Leonard G, Posadas E, Herrmann P, et al. Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review. Leuk Lymphoma. 2004;45(12):2521-2525. (Pubitemid 40081202)
4. Kaplan DH, Shankaran V, Dighe AS, et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A. 1998;95(13):7556-7561. (Pubitemid 28293291)
5. Shankaran V, Ikeda H, Bruce AT, et al. IFN-gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001;410(6832):1107-1111. (Pubitemid 32391043)
6. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137-148.
7. Camcioglu Y, Picard C, Lacoste V, et al. HHV-8-associated Kaposi sarcoma in a child with IFN-gammaR1 deficiency. J Pediatr. 2004;144(4):519-523. (Pubitemid 38457358)
8. Kraut EH. Clinical manifestations and infectious complications of hairy-cell leukaemia. Best Pract Res Clin Haematol. 2003;16(1):33-40. (Pubitemid 36432133)
9. Goldschmidt N, Nusair S, Gural A, Amir G, Izhar U, Laxer U. Disseminated Mycobacterium kansasii infection with pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia. Am J Hematol. 2003;74(3):221-223. (Pubitemid 37363028)
10. Dirksen U, Nishinakamura R, Groneck P, et al. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest. 1997;100(9):2211-2217. (Pubitemid 27500143)
11. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med. 1999;190(6):875-880. (Pubitemid 29451632)
12. Thomassen MJ, Yi T, Raychaudhuri B, Malur A, Kavuru MS. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clin Immunol. 2000;95(2):85-92. (Pubitemid 30317817)
13. Kitamura T, Uchida K, Tanaka N, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2000;162(2):658-662. (Pubitemid 30647215)
14. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002;166(2):215-235.
15. Patel SY, Ding L, Brown MR, et al. Anti-IFN-γ autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol. 2005;175(7):4769-4776. (Pubitemid 41362019)
16. Koziel J, Maciag-Gudowska A, Mikolajczyk T, et al. Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors. PLoS ONE. 2009;4(4):e5210.
17. Holland SM, Eisenstein EM, Kuhns DB, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: a preliminary report. N Engl J Med. 1994;330(19):1348-1355. (Pubitemid 24984697)
18. Vinh DC, Shea YR, Sugui JA, et al. Invasive aspergillosis due to Neosartorya udagawae. Clin Infect Dis. 2009;49(1):102-111.
19. Ballas ZK, Turner JM, Turner DA, Goetzman EA, Kemp JD. A patient with simultaneous absence of "classical" natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset. J Allergy Clin Immunol. 1990;85(2):453-459.
20. Couderc LJ, Epardeau B, Dazza MC, et al. Disseminated Mycobacterium avium intracellulare infection without predisposing conditions. Lancet. 1992;340(8821):731.
21. Couderc LJ, Bernaudin JF, Epardeau B, Caubarrere I. Pulmonary alveolar proteinosis and disseminated Mycobacterium avium infection. Respir Med. 1996;90(10):641-642. (Pubitemid 26385896)
22. Wendland T, Herren S, Yawalkar N, Cerny A, Pichler WJ. Strong [alpha][beta] and [gamma] [delta] TCR response in a patient with disseminated Mycobacterium avium infection and lack of NK cells and monocytopenia. Immunol Lett. 2000;72(2):75-82. (Pubitemid 30332302)
23. Khanjari F, Watier H, Domenech J, Asquier E, Diot P, Nakata K. GM-CSF and proteinosis. Thorax. 2003;58(7):645.
24. Witzke O, Patschan D, Durig J, et al. A patient without monocytes who had pulmonary renal syndrome. Am J Kidney Dis. 2004;44(3):556-558. (Pubitemid 39164632)
25. Kobashi Y, Yoshida K, Niki Y, Oka M. Sibling cases of Mycobacterium avium complex disease associated with hematological disease. J Infect Chemother. 2006;12(5):331-334.
26. Tarling JD, Lin HS, Hsu S. Self-renewal of pulmonary alveolar macrophages: evidence from radiation chimera studies. J Leukoc Biol. 1987;42(5):443-446.
27. Sawyer RT, Strausbauch PH, Volkman A. Resident macrophage proliferation in mice depleted of blood monocytes by strontium-89. Lab Invest. 1982;46(2):165-170.
28. Landsman L, Jung S. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J Immunol. 2007;179(6):3488-3494.
29. Murphy J, Summer R, Wilson AA, Kotton DN, Fine A. The prolonged life-span of alveolar macrophages. Am J Respir Cell Mol Biol. 2008;38(4):380-385.
30. van Furth R, Diesselhoff-den Dulk MM. Dual origin of mouse spleen macrophages. J Exp Med. 1984;160(5):1273-1283.
31. Crofton RW, Diesselhoff-den Dulk MM, van Furth R. The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state. J Exp Med. 1978;148(1):1-17.
32. Thomas ED, Ramberg RE, Sale GE, Sparkes RS, Golde DW. Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science. 1976;192(4243):1016-1018.
33. Gale RP, Sparkes RS, Golde DW. Bone marrow origin of hepatic macrophages (Kupffer cells) in humans. Science. 1978;201(4359):937-938.
34. Iwasaki H, Mizuno S-i Arinobu Y, et al. The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev. 2006;20(21):3010-3021.
35. Friedman AD. Transcriptional control of granulocyte and monocyte development. Oncogene. 2007;26(47):6816-6828. (Pubitemid 47585105)
36. Thaker H, Neilly IJ, Saunders PG, Magee JG, Snow MH, Ong EL. Remember mycobacterial disease in hairy cell leukaemia (HCL). J Infect. 2001;42(3):213-214.
37. Janckila AJ, Wallace JH, Yam LT. Generalized monocyte deficiency in leukaemic reticuloendotheliosis. Scand J Haematol. 1982;29(2):153-160.
38. Bouroncle BA. Leukemic reticuloendotheliosis (hairy cell leukemia). Blood. 1979;53(3):412-436.
39. Rice L, Shenkenberg T, Lynch EC, Wheeler TM. Granulomatous infections complicating hairy cell leukemia. Cancer. 1982;49(9):1924-1928.
40. Riccioni R, Galimberti S, Petrini M. Hairy cell leukemia. Curr Treat Options Oncol. 2007;8(2):129-134.
41. Randolph GJ, Jakubzick C, Qu C. Antigen presentation by monocytes and monocyte-derived cells. Curr Opin Immunol. 2008;20(1):52-60.
42. Landsman L, Varol C, Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol. 2007;178(4):2000-2007. (Pubitemid 46233396)
43. Villadangos JA. Hold on, the monocytes are coming! Immunity. 2007;26(4):390-392.
44. Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med. 2008;177(7):752-762.
45. Dirksen U, Nishinakamura R, Groneck P, et al. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest. 1997;100(9):2211-2217. (Pubitemid 27500143)
46. Shoji N, Ito Y, Kimura Y, et al. Pulmonary alveolar proteinosis as a terminal complication in myelodysplastic syndromes: a report of four cases detected on autopsy. Leuk Res. 2002;26(6):591-595. (Pubitemid 34462173)
47. Inaba H, Jenkins JJ, McCarville MB, et al. Pulmonary alveolar proteinosis in pediatric leukemia. Pediatr Blood Cancer. 2008;51(1):66-70.
48. Woodworth CD. HPV innate immunity. Front Biosci. 2002;7:2058-2071.
49. Eidenschenk C, Dunne J, Jouanguy E, et al. A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8. Am J Hum Genet. 2006;78(4):721-727.
50. Orange JS. Human natural killer cell deficiencies and susceptibility to infection. Microb Infect. 2002;4(15):1545-1558. (Pubitemid 36050824)
51. Kitaya K. Accumulation of uterine CD16(-) natural killer (NK) cells: friends, foes, or Jekyll-and-Hyde relationship for the conceptus? Immunol Invest. 2008;37(5):467-481.
52. zur Hausen H. Papillomaviruses in the causation of human cancers: a brief historical account. Virology. 2009;384(2):260-265.
53. Kutok JL, Wang F. Spectrum of Epstein-Barr virus associated diseases. Annu Rev Pathol. 2006;1:375-404.
54. Du MQ, Bacon CM, Isaacson PG. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders. J Clin Pathol. 2007;60(12):1350-1357. (Pubitemid 350247250)
55. Javier RT, Butel JS. The history of tumor virology. Cancer Res. 2008;68(19):7693-7706.
56. Liesveld JL, Jordan CT, Phillips GL II. The hematopoietic stem cell in myelodysplasia. Stem Cells. 2004;22(4):590-599.
57. Nimer SD. Myelodysplastic syndromes. Blood. 2008;111(10):4841-4851.
58. Owen C, Barnett M, Fitzgibbon J. Familial myelodysplasia and acute myeloid leukaemia: a review. Br J Haematol. 2008;140(2):123-132. (Pubitemid 350265048)
59. Maserati E, Minelli A, Menna G, et al. Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects. Cancer Genet Cytogenet. 2004;148(2):155-158. (Pubitemid 38087963)
60. Paulsson K, Johansson B. Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes. Pathol Biol (Paris). 2007;55(1):37-48.